Oncogenic activation of the ETS Related Gene (ERG) in humans was originally identified in subsets of Ewing sarcomas, myeloid leukemias and, recently, in the majority of prostate cancers. Expression of human ERG protein and consequently its functions in normal and disease states needs to be better understood in light of its suggested role in cell differentiation and proliferation. Here, we analyzed temporal and spatial expression of the Erg (mouse protein) by immunohistochemical analysis during mouse embryonic and adult organogenesis using a highly specific ERG monoclonal antibody (ERG MAb). This study establishes widespread immunolocalization of Erg protein in endothelial cells and restricted expression in precartilage and hematopoietic tissues. Intriguingly, Erg is not expressed in any epithelial tissue including prostate epithelium, or in infiltrating lymphocytes that are occasionally seen in the prostate environment, a common site of tumors with ERG rearrangements and unscheduled ERG expression. These findings will further aid in investigations of Erg functions in normal and disease conditions.
Introduction
Chromosomal translocations leading to gene fusions have been well characterized in variety of malignancies [1] . G e n e f u s i o n s o f t e n r e s u l t i n c h i m e r i c proteins with aberrant functions and/or ectopic expression. Frequent elevated expression of the ETS related genes (ERG) due to chromosomal rearrangements resulting into the fusion between androgen regulated promoters (predominatlyTMPRSS2) and protein coding sequence of ETS transcription factors has been established in prostate cancer [2, 3] . ETS (Erythroblast Transformation Specific family of transcription factors) genes are a large family with at least thirty members that function as transcription factors [4] . All ETS transcription factors share a highly conserved DNA binding domain, the ETS domain [5] and at least Ets1, Erg, Fli1 and Etv2 are expressed in embryonic endothelial cells of mouse [6, 7] . ERG is well conserved in evolution and its expression and poten-tial functions have been studied in xenopus, zebrafish, mouse and humans [8] [9] [10] [11] [12] . T h e r e s u l t s f r o m t h e s e studies suggest an emerging role for ERG in the transcriptional regulation of endothelial specific genes [13] [14] [15] [16] and in definitive hematopoiesis [17, 18] . Both hematopoietic and endothelial cells are of mesodermal origin and are derived from the hemangioblast, a common precursor, suggesting a shared developmental pathway [19] . Knock-down of Erg is associated with a significant reduction in the formation of vascular structures and the number of endothelial cells [20] and with apoptosis [21] . These studies indicate that Erg may have important implications in vascular development during mouse embryogenesis. Although Erg does not appear to be required for hematopoiesis during embryonic stem cell differentiation, it may play a role in endothelial cell differentiation [20] . Hematopoietic stem cells give rise to both T-and B-lymphocytes in embryogenesis and throughout adult li f e . A l t h o u g h m a t u r e T -lymphocytes do not express Erg, expression is detected transiently during T-lineage specification and is silenced after their commitment [22] . During B-cell development in the mouse, Erg expression was detected in early pre-B cells, pre-B and in mature B cells [23] . In developing mouse, Erg mRNA is expressed in mesodermal tissues such as endothelial cells, mesenchymal condensations during precartilaginous depositions, and in urogenital regions [11] . All of the expression studies were carried out by using RT-PCR or in situ hybridization. However, the protein expression and its cellular distributions could not be pe r f o r m e d d u e t o a l a c k o f a n Erg-specific antibody.
The goal of this study was to establish the expression pattern of Erg protein in developing and adult mouse tissues by using an ERG-specific antibody. These data would serve as a basis to understand the function of Erg during normal development in many organs and pathological conditions, such as its cancer-specific expression in prostatic adenocarcinoma. Although several antibodies for detecting human E R G p r o t e i n a n d m o u s e E r g p r o t e i n h a v e b e e n d escribed, due to high degree of homology among ETS family members, in particular its closest homologue Fli-1, a n t i b o d y c r o s s r e a c t i v i t y h a s b e c o m e a m a j o r concern in detection of the ERG protein. Recently, we have generated and characterized an ERG-specific mouse monoclonal antibody that showed high specificity towards ERG protein that does not cross react with FLI-1 protein [24] . In the present study, we examined the detailed expression of the Erg protein during prenatal and adult mouse organogenesis.
Results and discussion
Evaluation of ERG Monoclonal Antibodies for the Specificity of ERG Protein Detection: We evaluated the specificity of three recently available ERG monoclonal antibodies including the ERG MAb that we recently reported [24] . As noted previously, the ERG MAb detected ERG protein products in MOLT4, KG1, COLO 320 and VCaP tumor cell lines, whereas LNCaP, MCF7 and Jurkat cell lines were negative for ERG. The ERG MAb did not show cross reactivity to FLI-1 in LNCaP cells infected with a FLI-1 adenovirus expression vector (Fig 1A) . Under similar assay conditions, rabbit monoclonal antibodies to ERG (EPR 3 8 6 4 a n d E P R 3 8 6 3 ) o b t a i n e d f r o m E p i t o m i c s ( B u rlingame, CA) detected FLI-1 in LNCaP cells infected with a FLI-1 adenovirus expression vector (Fig 1B,  1C) . In addition, a rabbit monoclonal ERG antibody EPR 3864 detected a protein in Jurkat cell line (acute T cell leukemia) that was not recognized by either the r a b b i t m o n o c l o n a l a n t i b o d y E P R 3 8 6 3 o r o u r E R G M A b s u g g e s t i n g p o t e n t i a l c r o s s r e activity to other ETS related proteins by EPR 3864. Interestingly, other monoclonal ERG antibody EPR 3863 recognized FLI-1 in LNCaP cells infected with a FLI-1 adenovirus expression vector. Taken together, the results obtained from immunoblot analyses suggest that the ERG MAb we developed is highly specific for ERG protein detection and was further assessed in other immunoassays.
To determine the efficiency of ERG MAb antib ody in a p r ost at e t um or m odel, w e ana ly zed E R G expression in ERG-positive VCaP and ERG-negative LNCaP prostate cancer cell tumor xenografts in SCID mice. The ERG MAb antibody detected ERG protein in VCaP xenografts, staining primarily the nuclei with some cytoplasmic reactivity (Fig 2A) . As expected, ERG negative LNCaP xenografts did not show ERG expression. The endothelial cells lining the blood vessels and capillaries showed positive reactivity to ERG MAb in tumors as well as normal adjacent tissue (Fig 2B) . Further, we evaluated the ERG MAb for the detection of ERG protein the prostates of ERG-transgenic mice [25] . Transgenic ERG expression was detected in the prostate luminal epithelial cells of ERG-transgenic mice (Fig 2C) . In addition, endogenous Erg protein was detected only in the endothelial cells of blood vessels and capillaries (Fig 2D) . Infiltrating lymphocytes did not show immune-reactivity t o ERG MAb (Fi g 2 E , G ) . C onsist ent w it h a recent report [26] , rabbit monoclonal antibodies EPR 3864 showed a strong staining of lymphocytic infiltration in prostate gland (Fig 2F, H) . Interestingly, both the rabbit monoclonal ERG antibodies (EPR 3864, EPR 3863) and FLI-1 antibodies have shown reactivity to infiltrating lymphocytes (Fig 2I, J) . It is interesting to note that ERG is turned on at transition stage (between precursor and pro-T stage 1) of T-cell different i a t i o n a n d d o e s n o t p e r s i s t s t a b l y t o d e f i n e T -cell identity, and is shut off after T cell lineage commitment [22, 27, 28] . In this study, we have not characterized the trans i e n t e x p r e s s i o n o f E r g d u r i n g T -cell development and differentiation.
To study the utility of the ERG MAb to detect the expression of ERG in cells using flow cytometry, s e v e n h u m a n c a n c e r c e l l l i n e s , V C a P a n d L N C a P (prostate cancer), T2 and Jurkat (T lymphoblastoid cells), KG-1 and KG-1a (myeloblastic) were analyzed. All cell lines were permeabilized by standard cell intracellular staining methods by using detergent followed by incubation with the ERG MAb and secondary fluorochrome-conjugated antibodies. As shown in Fig 3 C a n d D , e x p r e s s i o n o f E R G w a s clearly detectable in the TMPRSS2-ERG fusion-harboring VCaP ce ll s and w as no t observed in the TMPRSS2-ERG negative LNCaP cells (Fig 3A, 3B ). I n t h e c a s e o f t h e h e m atopoietic/lymphoblastoid cancer cells of the T lymphocyte lineage, ERG expression was detected neither in T2 (Fig 3I, 3J ) nor in Jurkat cells (Fig 3K, 3L) . With the hematopoietic cell lines of myeloid lineage, KG-1 and KG-1a, the expression of ERG was clearly detectable in both cell lines (Fig 3E, 3 F a n d F i g 3 G , 3 H ) . I n t e r e s t i n g l y , t h e K G -1a cells, w hich are co nsider ed t o b e le ss m at u re or di fferentiated t h a n t h e K G -1 cells, expressed much higher amounts of the ERG protein. Taken together, the consistent results of Western blot, IHC and FACS assays established the specificity of the ERG MAb in detecting ERG protein in different assay platforms and biological specimen contexts. Erg protein expression in prenatal mouse development: D u r i n g E 9 . 5 d , s t r o n g e x p r e s s i o n o f E r g protein was detected by the ERG MAb mainly in the endothelial cells of blood vessels around the neural tube (Fig 4A, 4B) . Additionally, expression was also prominent in the cells that line the amnion (Fig 4A) . At this stage, during heart development, the ventricle begins trabeculation to demarcate this region from the primitive heart. E x p r e s s i o n o f E r g w a s o b s e r v e d i n endothelial cells that line the trabeculated regions of the ventricle (Fig 4C) . Endothelial cells present in the inter-somitic capillaries show strong expression of Erg (Fig 4D) . Similar endothelial-specific expression was found in the dorsal aorta and around the neural tube (Fig 4E) . The distribution observed with ERG MAb antibody is consistent with earlier reported studies of Erg mRNA expression [11, 20] . Similar to earlier stages of development, at E12.5d, Erg expression was endothelial cell-specific in the majority of the tissues (Fig 5) . In addition to endothelial expression, Erg expression was detected in the precartilage/ cartilage primordium of the nasal septum, neural arch and rib (Fig 5A, 5B, 5C ). Mesenchymal condensations are required at this stage to initiate the paving cartilage path for both transient and permanent cartilage. The transient cartilage will undergo ossification to form bone. Interestingly, Erg expression was observed only in the precartilage primordium suggesting that Erg may have critical role in the differentiation of cartilage. Heart development at this stage exhibited extensive trabeculation of the ventricle and showed clear lining of endothelial cells with positive Erg staining along the trabeculated endocardium (Fig 5B) . (Fig 5D) . Epithelial cells of segmental bronchus did not show Erg expression (Fig 5D) . Kidney at this stage starts subdividing into cortical and medullary regions. Expression was detected only in the blood vessels and capillaries uniformly throughout the kidney and not in the kidney cortex or medulla (Fig 5E) . 
(C) Erg protein was detectable in the precartillage condensations in the neural arch (na). (D) Higher magnification of developing lungs (not yet divided into lobes) show lack of expression in the epithelial cells of segmental bronchus (sb). Surrounding stroma with enrihed capillaires exhibit strong staining. (E). Expression is seen only in endothelial cells of the blood vessels and capillaries uniform throughout the kidney.

E r g e x p r e s s i o n i n E 1 4 . 5 d w a s f o u n d m o s t l y i n t h e e n d o t h e l i a l c e l l s o f v a r i e t y o f t i s s u e s ( F i g 6 ) .
I n developing liver, about 1-2% of liver cells exhibited reactivity with ERG MAb antibody and megakaryocytes did not show Erg expression. Expression in the cartilage appeared to be reduced significantly compared to E12.5d in the rib, nasal septum and vertebrae. We found significant differences between ERG MAb and rabbit monoclonal ERG antibodies EPR 3864 megakaryocytic immunostaining. No significant changes in the Erg expression patterns were observed i n t h e l a t e r s t a g e s o f m o u s e d e v e l o p m e n t . As the overexpression of ERG in the prostate is implicated in the oncogenic process, we examined the normal expression of Erg protein in developing prostate glands. In the mouse, the prostatic buds first emerge at the rostral end of the urogenital sinus at approximately 17.5 days of gestation and subsequently, the prostatic epithelial buds undergo extensive ductal outgrowth and branching morphogenesis into the surrounding mesenchyme during the first three weeks of postnatal development. Interestingly, Erg staining was observed only in the mesenchymal compartment and restricted to capillary endothelial cells (Fig 7) suggesting that Erg may not be critical in normal prostate development or differentiation. (Fig 8A) . However, rabbit monoclonal ERG antibodies EPR 3864 showed a strong staining in megakaryocytes, in addition to endothelial and other cell types (Fig 8B) .
Expression of Erg protein in adult mice: We extended our study to adult mouse tissues to analyze the expression of Erg protein (Fig 9) . Similar to embryonic tissues, the expression of Erg was observed in the endothelial cells of the adrenal gland, cartilaginous component of bone, heart muscle, kidney, liver, lung, spleen urinary bladder. Erg expression was also evident in the lymphatic endothelial cells in adult mouse. As expected, expression was undetectable in the prostate epithelium. Detailed examination of these tissues has revealed that the expression was mostly restricted to hematopoietic and endothelial compartments. In liver, the expression appeared to be in the K u p f f e r c e l l s . I n b o n e m a r r o w , ERG MAb did not show reactivity with megakaryocytes. Interestingly, eosinophils, with a characteristic ring shaped or segmented/multilobed nuclei stained the nuclei with ERG MAb. Eosinophils are derived from hematopoietic stem cells initially committed to the myeloid line and then to the basophil-eosinophil granulocyte lineage. The presence of Erg in these cells suggest its potential function in either differentiation or maintenance of differentiation state. During development, Fli1 is preferentially expressed in hematopoietic cells, endothelial cells and in the mesenchyme which is mainly derived from neural crest cells [29] . Similar to earlier observations [11] we also observe the co-expression of the Erg and Fli1 genes in both endothelial and mesodermal tissues, including urogenital tract and precartilaginous areas. Similar to Erg, Fli1 expression also appeared transient during mouse e m b r y o g e n e s i s . T h i s r e s u l t i s c o n s i s t e n t w i t h s u b t l e temporal regulation. Whether this spatiotemporal overlap determines redundant functions or not remains to be determined. Due to specificity and clarity of Erg detection in developing and adult mouse tissues, these findings will be valuable in further assessing in vivo functions of Erg in normal and malignant tissues. 
Materials and Methods
Antibodies: Recently, we have reported the generation and characterization of mouse monoclonal antibodies to ERG, showing higher specificity [24] . In this study, we have used mouse monoclonal ERG antibodies along with the other commercially available ERG antibodies, a rabbit anti-ERG monoclonal antibody clone EPR 3864 (Cat No. 2805-1) [26] . Cell lysates equivalent to 50 μg of protein were separated on 4-12% Bis-Tris Gel (Invitrogen, Carlsbad, CA) and transferred to PVDF membrane (Invitrogen, Carlsbad, CA). Membranes were incubated with primary antibodies: Anti-ERG mouse monoclonal antibody (ERG MAb) [24] (1:500 dilution), rabbit monoclonal ERG (EPR 3864 and EPR 3863) antibodies (1:500 dilution) anti-GAPDH (sc-25778, Santa Cruz Biotechnology, Santa Cruz, CA) at 4°C for overnight. Membranes were washed three times for 5 minutes each at room temperature followed by treatment with secondary antibodies: sheep anti-mouse IgG-HRP or donkey anti-rabbit IgG-HRP at 24°C for 1 hour. Finally membranes were washed three times and bands were visualized with ECL Western blot detection reagent (GE Health Care, Buckinghamshire, UK).
Immunofluorescence staining for ERG in cell lines and flow cytometry analysis. The cancer cell lines used in this study were obtained from ATCC. Then cells were washed and stained with FITC-conjugated rat anti-mouse IgG1 antibody (Clone A85-1, BD Pharmingen) for an additional 30 minutes at 4 o C. Cells were then washed and analyzed by using a B D F A C S C a n t o I I f l o w cytometer. Data was coll e c t e d o n t h e t o t a l c e l l p o p u l a t i o n a n d t h e a n a l y s i s was performed by using FACS Diva software (version 5 .03) (Becton Dickinson). Tissues and processing for Immunohistochemistry: Fixation and impregnation FVB/N a n d C 5 7 B L 6 m i c e e m b r yos from various stages of development were dissected from pregnant females, washed in ice-cold phosphate-buffered saline (PBS) and fixed in ice-cold 4% paraformaldehyde overnight, sequentially dehydration, embedding, and sectioning steps were performed acc o r d i n g t o e s t a b l i s h e d p r otocols.
Preparation for staining: Slides (with 5-mm sections) were warmed at 60 o C for 15 minutes and immediately immersed in xylene for effective removal of paraffin and processed additionally twice in xylene for 5 min each, washed twice in 100% ethanol for 5 m i n e a c h , a n d s u b s e q u e n t l y r e h y d r a t e d i n 9 5 , 7 5 % ethanol, and PBS for 5 min at room temperature.
Immunohistochemistry: Antigen retrieval was performed on these slides in Antigen unmasking solution (Vector Biolabs, Burlingame, CA) by using vegetable steamer for 45 minutes and the slides were allowed to cool to room temperature for about 30 min. Slides were washed twice in 1xPBS and treated with 3% H 2 O 2 in ultrapure water for 15 minutes to quench the endogenous peroxidase activity. Immunodetection was performed using Mouse-to-mouse detection system kit according manufacturer's instructions (Millipore Inc. Billerica, MA). Briefly, nonspecific binding of the antibody was blocked by incubating the slides with pre-blocking solution for 10 minutes at RT, primary antibodies (200 pg/ml in 10% normal goat serum) at 4 o C overnight or room temperature for 2 h o u r s . S l i d e s w e r e w a s h e d t w i c e i n 1 x P B S s i t e s 5 min each, incubated with post-antibody blocking solution for 10 min. Slides were washed twice in 1xPBS sites 5 min each and incubated with ready-to-use poly-HRP-Anti-Mouse/Rabbit I g G f o r 3 0 m i n u t e s , washed twice with 1xPBS for 5 minutes each. Color development was performed by using DAB as a substrate for peroxidase enzyme activity. The color reaction was stopped by washing/rinsing slides in tap water several times. Slides were counterstained with Hematoxylene for 2 minutes, rinsed in tap water for 5 mins, dehydrated sequentially in ascending concentration of alcohol, cleared in xylene and permanently m o u n t e d w i t h P e r m o n t s o l u t i o n . T h e s l i d e s w e r e scanned in Biomedical Instrumentation Center at Uniformed Services University of the Health Sciences using Olympus NanoZoomer Digital Pathology microscope at 40X magnification and digital images were taken from the scans.
